Colgate-Palmolive (NYSE:CL) Receives $102.17 Consensus Price Target from Analysts

Shares of Colgate-Palmolive (NYSE:CL - Get Free Report) have earned an average rating of "Hold" from the twenty-one analysts that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and eleven have given a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $102.39.

CL has been the subject of several research reports. StockNews.com raised Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Tuesday. Piper Sandler cut their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a report on Monday, March 31st. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. Raymond James reissued an "outperform" rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, Wells Fargo & Company increased their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 2nd.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Westend Capital Management LLC boosted its holdings in shares of Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 140 shares in the last quarter. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth $27,000. Cornerstone Planning Group LLC raised its stake in Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after purchasing an additional 287 shares during the last quarter. Finally, Vermillion Wealth Management Inc. purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $31,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

CL traded down $0.14 during midday trading on Tuesday, hitting $92.19. 5,914,365 shares of the company were exchanged, compared to its average volume of 4,668,287. The firm has a market capitalization of $74.77 billion, a price-to-earnings ratio of 26.19, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company's 50 day simple moving average is $92.28 and its 200 day simple moving average is $92.06. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The firm had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The company's quarterly revenue was down 3.0% on a year-over-year basis. During the same period last year, the firm earned $0.86 EPS. As a group, sell-side analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive announced that its Board of Directors has authorized a share buyback program on Thursday, March 20th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its shares are undervalued.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.26%. Colgate-Palmolive's dividend payout ratio is 59.09%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.